CN1688589A - β－内酰胺酶抑制剂前体药物 - Google Patents

β－内酰胺酶抑制剂前体药物 Download PDF

Info

Publication number
CN1688589A
CN1688589A CNA038243164A CN03824316A CN1688589A CN 1688589 A CN1688589 A CN 1688589A CN A038243164 A CNA038243164 A CN A038243164A CN 03824316 A CN03824316 A CN 03824316A CN 1688589 A CN1688589 A CN 1688589A
Authority
CN
China
Prior art keywords
prodrug
heptane
oxo
thia
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038243164A
Other languages
English (en)
Chinese (zh)
Inventor
安东尼·马法特
戴尔·G·麦克利奥德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of CN1688589A publication Critical patent/CN1688589A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CNA038243164A 2002-08-23 2003-08-11 β－内酰胺酶抑制剂前体药物 Pending CN1688589A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40564002P 2002-08-23 2002-08-23
US60/405,640 2002-08-23

Publications (1)

Publication Number Publication Date
CN1688589A true CN1688589A (zh) 2005-10-26

Family

ID=31946909

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038243164A Pending CN1688589A (zh) 2002-08-23 2003-08-11 β－内酰胺酶抑制剂前体药物

Country Status (31)

Country Link
US (1) US7091197B2 (https=)
EP (1) EP1534717B1 (https=)
JP (1) JP2005539037A (https=)
KR (1) KR20050037583A (https=)
CN (1) CN1688589A (https=)
AP (1) AP2005003231A0 (https=)
AR (1) AR041028A1 (https=)
AT (1) ATE349452T1 (https=)
AU (1) AU2003250489A1 (https=)
BR (1) BR0313683A (https=)
CA (1) CA2494953A1 (https=)
DE (1) DE60310733D1 (https=)
EA (1) EA007540B1 (https=)
EC (1) ECSP055625A (https=)
GT (1) GT200300179A (https=)
HR (1) HRP20050162A2 (https=)
IL (1) IL166719A0 (https=)
IS (1) IS7693A (https=)
MA (1) MA27387A1 (https=)
MX (1) MXPA05001446A (https=)
NO (1) NO20051497D0 (https=)
NZ (1) NZ538340A (https=)
OA (1) OA12909A (https=)
PA (1) PA8579701A1 (https=)
PE (1) PE20040899A1 (https=)
PL (1) PL375988A1 (https=)
TN (1) TNSN05054A1 (https=)
TW (1) TWI250162B (https=)
UY (1) UY27947A1 (https=)
WO (1) WO2004018484A1 (https=)
ZA (1) ZA200501513B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104159587A (zh) * 2012-01-06 2014-11-19 南佛罗里达大学 组合物、使用方法、以及治疗方法
CN109422765A (zh) * 2017-09-05 2019-03-05 香港理工大学深圳研究院 C类β-内酰胺酶抑制剂及其制备方法和应用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004108733A1 (en) * 2003-06-05 2004-12-16 Pfizer Products Inc. Beta-lactamase inhibitor prodrug
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
EP1913378A1 (de) * 2005-07-29 2008-04-23 Sigma-Aldrich Production GmbH Ionisierungsadditive enthaltende lc/ms-blends
WO2010118968A1 (en) 2009-04-16 2010-10-21 Nicox S.A. No-donor aspirin derivatives
WO2013056163A1 (en) * 2011-10-14 2013-04-18 The Regents Of The University Of California Beta-lactamase inhibitors

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE34011B1 (en) 1969-03-13 1975-01-08 Leo Pharm Prod Ltd New penicillin esters
IE34019B1 (en) 1969-03-18 1975-01-08 Leo Pharm Prod Ltd New semi-synthetic penicillin esters
GB1267936A (en) 1969-05-28 1972-03-22 Beecham Group Ltd DERIVATIVES OF alpha-AMINOPENICILLINS
US3957764A (en) 1969-11-11 1976-05-18 Lovens Kemiske Fabrik Produktionsaktieselskab 6-aminopenicillanic acid derivatives
US3862181A (en) 1970-10-28 1975-01-21 Squibb & Sons Inc Process for preparing cephalosporins
GB1315566A (en) 1970-11-06 1973-05-02 Leo Pharm Prod Ltd Penicillanic acid derivatives
CA996929A (en) 1971-04-05 1976-09-14 Kohzi Nakano Acyloxyalkyl ester derivatives of penicillin
GB1433131A (en) 1972-03-13 1976-04-22 Astra Laekemedel Ab Penicillins
GB1426717A (en) 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
US4397783A (en) 1979-03-05 1983-08-09 Pfizer Inc. Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners
DE2927004A1 (de) * 1979-07-04 1981-05-27 Bayer Ag, 5090 Leverkusen Penicillansaeure-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel als arzneimittel
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
US4432970A (en) 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use
JPS5849387A (ja) 1981-09-17 1983-03-23 Sankyo Co Ltd ７−メトキシセフアロスポリン化合物およびその製法
DE3274453D1 (en) * 1981-09-22 1987-01-15 Kureha Chemical Ind Co Ltd Penicillin derivatives
US4406887A (en) 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
US4428935A (en) * 1982-05-24 1984-01-31 Pfizer Inc. Penicillanic acid dioxide prodrug
US4521533A (en) 1984-07-12 1985-06-04 Pfizer Inc. Salts of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide esters and beta-lactam antibiotics
DE3901405A1 (de) 1989-01-19 1990-07-26 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
JPH03206038A (ja) 1990-01-08 1991-09-09 Yoshitomi Pharmaceut Ind Ltd 抗菌剤
GB9001405D0 (en) 1990-01-22 1990-03-21 Leo Pharm Prod Ltd New intermediates,their production and use
GB9208492D0 (en) 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
WO2004108733A1 (en) 2003-06-05 2004-12-16 Pfizer Products Inc. Beta-lactamase inhibitor prodrug

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104159587A (zh) * 2012-01-06 2014-11-19 南佛罗里达大学 组合物、使用方法、以及治疗方法
CN109422765A (zh) * 2017-09-05 2019-03-05 香港理工大学深圳研究院 C类β-内酰胺酶抑制剂及其制备方法和应用

Also Published As

Publication number Publication date
EA007540B1 (ru) 2006-10-27
PA8579701A1 (es) 2005-05-24
US7091197B2 (en) 2006-08-15
NO20051497L (no) 2005-03-21
PL375988A1 (en) 2005-12-12
IL166719A0 (en) 2006-01-15
UY27947A1 (es) 2004-03-31
IS7693A (is) 2005-02-10
TNSN05054A1 (fr) 2007-05-14
GT200300179A (es) 2004-05-18
ECSP055625A (es) 2005-04-18
MXPA05001446A (es) 2005-06-06
US20040110740A1 (en) 2004-06-10
DE60310733D1 (de) 2007-02-08
EA200500398A1 (ru) 2005-08-25
ATE349452T1 (de) 2007-01-15
OA12909A (en) 2006-10-13
BR0313683A (pt) 2005-06-21
ZA200501513B (en) 2006-09-27
EP1534717B1 (en) 2006-12-27
AR041028A1 (es) 2005-04-27
HRP20050162A2 (en) 2005-06-30
MA27387A1 (fr) 2005-06-01
CA2494953A1 (en) 2004-03-04
NZ538340A (en) 2006-10-27
WO2004018484A1 (en) 2004-03-04
AU2003250489A1 (en) 2004-03-11
AP2005003231A0 (en) 2005-03-31
TWI250162B (en) 2006-03-01
TW200417548A (en) 2004-09-16
JP2005539037A (ja) 2005-12-22
KR20050037583A (ko) 2005-04-22
EP1534717A1 (en) 2005-06-01
NO20051497D0 (no) 2005-03-21
PE20040899A1 (es) 2004-12-28

Similar Documents

Publication Publication Date Title
CN1137275A (zh) 具有免疫抑制活性的o-芳基、o-烷基、o-烯基和o-炔基大环内酯物
CN1032540A (zh) 新头孢烯类化合物及其制备方法
CN1013274B (zh) 头孢菌素衍生物的制备方法
CN1543465A (zh) 用作选择性细菌dhfr抑制剂的新的杂环化合物及其应用
CN1043042C (zh) 7－[2－(2－氨基噻唑－4－基)－2－(Z)－羟亚胺基－乙酰胺基]－3－(甲氧甲基)－3－头孢烯－4－羧酸－α－(2,2－二甲基丙酰氧)乙酯拆分的方法
CN1077957A (zh) 抗菌化合物
CN1291197A (zh) 新的乙酰胺衍生物及其用途
CN1688589A (zh) β－内酰胺酶抑制剂前体药物
CN1031533A (zh) 稳定的1-氧青霉烯-3-羧酸
CN1046286C (zh) 新的头孢烯衍生物
CN1025032C (zh) 制备2-甲氧基甲基-青霉烯衍生物的方法
CN1041596A (zh) 稳定的氧青霉烯-3-羟酸的制备及其作为β-内酰胺酶抑制剂的应用
CN88103202A (zh) 取代的乙烯基头孢菌素类化合物及其制备方法和作为药物的应用
CN1112364C (zh) 1,3,4－噻二唑碳青霉烯化合物及其制备方法和用途
CN1051562A (zh) 新颖的化合物
HK1079520A (en) Beta-lactamase inhibitor prodrug
CN1117095C (zh) 具有抗菌作用的取代的7－酰氨基－3－(甲基亚肼基)甲基头孢菌素和中间体
CN1096298A (zh) 七位上含有取代的氧亚氨基的新型头孢菌素、它们的制备方法和中间体及作为药物的用途
US20050004093A1 (en) Beta-lactamase inhibitor prodrug
CN86107742A (zh) 季胺化的2-位具有杂硫烷硫取代基的碳代氰霉烯
CN1044280A (zh) 头孢菌素衍生物及其制备方法
CN1064679A (zh) 醌类衍生物
CN1188417C (zh) 作为抗菌剂的3,6－二取代青霉砜衍生物
CN1300290A (zh) 新的头孢菌素化合物,其制备方法及含有它们的抗菌组合物
CN1745086A (zh) 用于改善药用化合物的生物利用度的羧酸酯

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1079520

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1079520

Country of ref document: HK